Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

5,448 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,448 results

Large-scale testing (Phase 3)Ended earlyNCT01387932
What this trial is testing

HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma
Merit Medical Systems, Inc. 235
Not applicableNot Yet RecruitingNCT06060847
What this trial is testing

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)

Who this might be right for
Carcinoma, HepatocellularMetabolic Syndrome
Ospedale V. Fazzi 50
Testing effectiveness (Phase 2)UnknownNCT03941626
What this trial is testing

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Who this might be right for
Esophagus CancerHepatomaGlioma+1 more
Shenzhen BinDeBio Ltd. 50
Early research (Phase 1)Study completedNCT01839604
What this trial is testing

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic
AstraZeneca 58
Not applicableLooking for participantsNCT06098547
What this trial is testing

LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)

Who this might be right for
Intrahepatic Cholangiocarcinoma
Azienda Sanitaria Ospedaliera 10
Testing effectiveness (Phase 2)Study completedNCT00914355
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 92
Not applicableLooking for participantsNCT05186116
What this trial is testing

LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis

Who this might be right for
Colon AdenocarcinomaLiver Metastasis Colon Cancer
Azienda Ospedaliero-Universitaria di Modena 25
Not applicableStudy completedNCT02635347
What this trial is testing

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

Who this might be right for
Liver FailureCarcinoma, Hepatocellular
Rutgers, The State University of New Jersey 31
Testing effectiveness (Phase 2)UnknownNCT04202978
What this trial is testing

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Who this might be right for
Hepatic Metastasis of Colorectal Cancer
Zhongshan Hospital Xiamen University 23
Not applicableActive Not RecruitingNCT03364621
What this trial is testing

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticHepatic Metastases
University Health Network, Toronto 17
Testing effectiveness (Phase 2)Ended earlyNCT02314052
What this trial is testing

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 21
Not applicableWithdrawnNCT05418387
What this trial is testing

A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona

Who this might be right for
Renal Cell CarcinomaHepatocellular Carcinoma
University of Arizona
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableNot Yet RecruitingNCT07685548
What this trial is testing

AI-Driven Tumor Response Evaluation for Solid Tumors

Who this might be right for
Solid Tumor CancerNeoplasmsHepatocellular Carcinoma
Shanghai Zhongshan Hospital 6,120
Not applicableLooking for participantsNCT06406244
What this trial is testing

Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy

Who this might be right for
Liver Cancer
West China Hospital 524
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Large-scale testing (Phase 3)UnknownNCT01436721
What this trial is testing

Use of an Oxidized Regenerated Cellulose After Hepatic Surgery

Who this might be right for
Liver Neoplasms
Fudan University 40
Not applicableStudy completedNCT01834014
What this trial is testing

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal Cancer
EPS Corporation 110
Not applicableEnded earlyNCT06419478
What this trial is testing

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis

Who this might be right for
Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical ProceduresImportance of Identifying Core Symptoms for Improving Symptom Management in PLC PatientsApplication of Network Analysis as a Crucial Component of Cancer Care
Mengmeng Yuan 249
Next Page